Evidence map›Paper›PMID 24695367›Full record

ArticleBiofabrication2014

Direct-write bioprinting of cell-laden methacrylated gelatin hydrogels.

Luiz E Bertassoni, Juliana C Cardoso, Vijayan Manoharan, Ana L Cristino, Nupura S Bhise, Wesleyan A Araujo, Pinar Zorlutuna, Nihal E Vrana, Amir M Ghaemmaghami, Mehmet R Dokmeci and 1 more

Abstract read
In one paragraph

Article in Biofabrication, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 173 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
173citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

173 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Review
  7. Review
  8. Stimuli-responsive hybrid materials for 4DMaterials today. Bio · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review

113 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Luiz E BertassoniBiomaterials Research Unit, Faculty of Dentistry, University of Sydney, Sydney, NSW 2010, Australia. Center for Biomedical Engineering, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02139, USA. Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Juliana C Cardoso
Vijayan Manoharan
Ana L Cristino
Nupura S Bhise
Wesleyan A Araujo
Pinar Zorlutuna
Nihal E Vrana
Amir M Ghaemmaghami
Mehmet R Dokmeci
Ali Khademhosseini

Funding

Microengineered Osteons for Bone Tissue EngineeringR01AR057837 · NIAMS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI YANG, YUNZHI · 2010 to 2018
$5.1M
3D combinatorial microenvironments for effective cell based therapyR01HL099073 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI KHADEMHOSSEINI, ALI, LIAO, RONGLIH · 2010 to 2013
$2.6M
Point-of-Care Rapid Blood Testing Using Microfluidic DevicesR01AI081534 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI DEMIRCI, UTKAN · 2009 to 2013
$2.1M
Engineering Vascularized Bone Tissues By Microfabrication And ScaffoldingR01DE021468 · NIDCR · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI YANG, YUNZHI · 2011 to 2014
$1.8M
Optical microresonator biosensors for high-throughput, real-time analysis of cellR01GM095906 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI VOLLMER, FRANK · 2011 to 2015
$1.8M
NHLBI NIH HHS HL099073NHLBI NIH HHS R01 HL099073NIAID NIH HHS AI081534NIAID NIH HHS R01 AI081534NIAMS NIH HHS AR057837NIAMS NIH HHS R01 AR057837NIBIB NIH HHS EB02597NIDCR NIH HHS DE021468NIDCR NIH HHS R01 DE021468NIGMS NIH HHS GM095906NIGMS NIH HHS R01 GM095906
6 · The paper itself

Abstract

Fabrication of three dimensional (3D) organoids with controlled microarchitectures has been shown to enhance tissue functionality. Bioprinting can be used to precisely position cells and cell-laden materials to generate controlled tissue architecture. Therefore, it represents an exciting alternative for organ fabrication. Despite the rapid progress in the field, the development of printing processes that can be used to fabricate macroscale tissue constructs from ECM-derived hydrogels has remained a challenge. Here we report a strategy for bioprinting of photolabile cell-laden methacrylated gelatin (GelMA) hydrogels. We bioprinted cell-laden GelMA at concentrations ranging from 7 to 15% with varying cell densities and found a direct correlation between printability and the hydrogel mechanical properties. Furthermore, encapsulated HepG2 cells preserved cell viability for at least eight days following the bioprinting process. In summary, this work presents a strategy for direct-write bioprinting of a cell-laden photolabile ECM-derived hydrogel, which may find widespread application for tissue engineering, organ printing and the development of 3D drug discovery platforms.

Indexed as

AnimalsBiocompatible MaterialsBioprintingCell SurvivalElastic ModulusGelatinHep G2 CellsHumansHydrogelsMethacrylatesMiceNIH 3T3 CellsTissue EngineeringTissue ScaffoldsBiocompatible MaterialsGelatinHydrogelsMethacrylates

Identifiers

PMID24695367
PMCPMC4040163

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.